И. Л. Халиф

2.2k total citations
34 papers, 1.4k citations indexed

About

И. Л. Халиф is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, И. Л. Халиф has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 16 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in И. Л. Халиф's work include Inflammatory Bowel Disease (18 papers), Microscopic Colitis (12 papers) and Gastrointestinal motility and disorders (5 papers). И. Л. Халиф is often cited by papers focused on Inflammatory Bowel Disease (18 papers), Microscopic Colitis (12 papers) and Gastrointestinal motility and disorders (5 papers). И. Л. Халиф collaborates with scholars based in Russia, United Kingdom and France. И. Л. Халиф's co-authors include Eamonn M.M. Quigley, Anton LeMair, Philippe Marteau, Jürgen M. Stein, Ivan V. Chopey, Bernd Bokemeyer, Christoph Gasché, Tariq Iqbal, Rayko Evstatiev and Khean‐Lee Goh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Clinical Gastroenterology and Hepatology.

In The Last Decade

И. Л. Халиф

32 papers receiving 1.3k citations

Peers

Countries citing papers authored by И. Л. Халиф

Since Specialization

Citations

This map shows the geographic impact of И. Л. Халиф's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by И. Л. Халиф with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites И. Л. Халиф more than expected).

Fields of papers citing papers by И. Л. Халиф

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by И. Л. Халиф. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by И. Л. Халиф. The network helps show where И. Л. Халиф may publish in the future.

Co-authorship network of co-authors of И. Л. Халиф

This figure shows the co-authorship network connecting the top 25 collaborators of И. Л. Халиф. A scholar is included among the top collaborators of И. Л. Халиф based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with И. Л. Халиф. И. Л. Халиф is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study 2023 ·Terapevticheskii arkhiv ·И. В. Маев, (unknown), И. Л. Халиф, Д. Н. Андреев	4
2	Skin diseases and inflammatory bowel diseases. Literature review 2020 ·SHILAP Revista de lepidopterología ·Tsviatko Alexandrov, И. Л. Халиф, (unknown), (unknown), М. В. Шапина	0
3	Diet with decreased content of fermentable oligo-, diand monosaccharides and polyols (low FODMAP-diet) in treatment of irritable bowel syndrome 2018 ·SHILAP Revista de lepidopterología ·И. Л. Халиф, (unknown)	1
4	Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients 2018 ·Inflammatory Bowel Diseases ·(unknown), (unknown), (unknown), М. В. Шапина, Ming‐Hsi Wang, И. Л. Халиф	20
5	Draft interdisciplinary guidelines for diagnosis, methods for estimation of the degree of activity, for evaluation of therapeutic efficacy, and for use of biological agents in patients with concomitant immunoinflammatory diseases (psoriasis, psoriatic arthritis, Crohn's disease) 2018 ·Modern Rheumatology Journal ·Д. И. Абдулганиева, (unknown), E. А. Belousova, (unknown), Т. В. Коротаева, Л. С. Круглова, (unknown), А. М. Лила, (unknown), И. Л. Халиф, (unknown)	11
6	IRRITABLE BOWEL SYNDROME. MODERN ASPECTS OF EPIDEMIOLOGY, PATHOGENESIS AND TREATMENT. A REVIEW. 2018 ·Experimental and Clinical Gastroenterology ·И. В. Маев, Д.С. Бордин, (unknown), (unknown), (unknown), (unknown), М. Ф. Осипенко, (unknown), (unknown), И. Л. Халиф, (unknown), (unknown)	8
7	USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES 2017 ·Meditsinskiy sovet = Medical Council ·М. В. Шапина, И. Л. Халиф	3
8	Inflammatory bowel disease treatment in Eastern Europe 2017 ·Current Opinion in Gastroenterology ·И. Л. Халиф, М. В. Шапина	9
9	Patterns of colonic dismotility and visceral hypersensitivity at various clinical variants of irritable bowel syndrome 2016 ·Russian Journal of Gastroenterology Hepatology Coloproctology ·(unknown), (unknown), И. Л. Халиф, (unknown)	5
10	Vedolizumab for inflammatory bowel diseases 2016 ·Russian Journal of Gastroenterology Hepatology Coloproctology ·И. Л. Халиф, М. В. Шапина	2
11	Colonic growth factors (G-CSF, GM-CSF) and chemokines (MCP-1, MIP-1β) in severe ulcerative colitis 2016 ·Russian Journal of Gastroenterology Hepatology Coloproctology ·(unknown), (unknown), М. В. Шапина, И. Л. Халиф	0
12	World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease 2016 ·Journal of Clinical Gastroenterology ·Çharles N. Bernstein, Abraham R. Eliakim, S S Fedail, Michael Fried, Richard B. Gearry, Khean‐Lee Goh, Saeed Hamid, Aamir Khan, И. Л. Халиф, Siew C. Ng, Qin Ouyang, Jean‐François Rey, Ajit Sood, Flávio Steinwurz, Gillian Watermeyer, Anton LeMair	154
13	CERTOLIZUMAB PEGOL IN CHOHN'S DISEASE (review) 2016 ·Koloproktologia ·М. В. Шапина, И. Л. Халиф, (unknown)	2
14	World Gastroenterology Organisation Global Guidelines Irritable Bowel Syndrome 2016 ·Journal of Clinical Gastroenterology ·Eamonn M.M. Quigley, Michael Fried, Kok‐Ann Gwee, И. Л. Халиф, A. P. S. Hungin, Greger Lindberg, Zaigham Abbas, Luis Bustos Fernández, Shobna Bhatia, Max Schmulson, Carolina Olano, Anton LeMair	92
15	Long-term results of medical treatment in patients with a severe attack of ulcerative colitis 2015 ·Terapevticheskii arkhiv ·И. Л. Халиф, (unknown), (unknown), О. В. Головенко	1
16	Efficiency of tacrolimus therapy for perianal Crohn’s disease 2015 ·Terapevticheskii arkhiv ·(unknown), A. V. Vardanyan, И. Л. Халиф	3
17	Acute Diarrhea in Adults and Children 2012 ·Journal of Clinical Gastroenterology ·Michael J.G. Farthing, Mohammed Abdus Salam, Greger Lindberg, Petr Dítě, И. Л. Халиф, Eduardo Salazar‐Lindo, Banumathi Ramakrishna, Khean‐Lee Goh, Alan Thomson, Aamir Ghafoor Khan, Justus Krabshuis, Anton LeMair	252
18	Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease 2012 ·Clinical Gastroenterology and Hepatology ·Rayko Evstatiev, Olga Alexeeva, Bernd Bokemeyer, Ivan V. Chopey, (unknown), (unknown), Tariq Iqbal, И. Л. Халиф, Philippe Marteau, Jürgen M. Stein, Christoph Gasché	86
19	World Gastroenterology Organisation Global Guideline: Irritable bowel syndrome: A global perspective - April 20, 2009 2009 ·Eamonn Martin Quigley, Michael Fried, Kok‐Ann Gwee, Carolina Olano, Francisco Guarner, И. Л. Халиф, Pali Hungin, Greger Lindberg, Zaigham Abbas, Luis Bustos Fernández, Fermín Mearin, (unknown), (unknown), Max Schmulson, Justus Krabshuis, A. Mair	5
20	Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation 2005 ·Digestive and Liver Disease ·И. Л. Халиф, Eamonn M.M. Quigley, (unknown), (unknown)	296

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact